QuidelOrtho Reports Second Quarter 2025 Financial Results
Provided By PR Newswire
Last update: Aug 5, 2025
― Labs revenue grew 4% as reported and 5% in constant currency ―
― Adjusted EBITDA margin improved by 330 basis points; Achieved $100 million annualized cost savings from initiatives announced in 2024 ―
― Company reiterates full-year 2025 financial guidance ―
